1. Department of Health. Immunisation against infectious disease 1990. London: HMSO, 1990.
2.Ramsay MEB, Corbel MJ, Redhead K, Ashworth LAE, Begg NT. Persistence of antibody after accelerated immunisation with diphtheria/tetanus/pertussis vaccine. BMJ 1991; 302: 1489–91.
3.Booy R, Aitken SJM, Taylor S, et al. Immunogenicity of combined diphtheria, tetanus, and pertussis vaccine given at 2, 3 and 4 months of age versus 3, 5 and 9 months of age. Lancet 1992; 339: 507–10.
4. Ad-hoc group for the study of pertussis vaccines. Placebo controlled trial of two acellular pertussis vaccines in Sweden - protective efficacy and adverse events. Lancet 1988; i: 955–60.
5.Blackwelder WC, Storsaeter J, Olin P, Hallander H. Acellular pertussis vaccines. Efficacy and evaluation of clinical case definitions. Amer J Dis Child 1991; 145: 1–6.
6. PHLS Epidemiological Research Laboratory and 21 Area Health Authorities. Efficacy of pertussis vaccination in England. BMJ 1982; 285: 357–9.
7.Jenkinson D. Duration of effectiveness of pertussis vaccine: evidence from a 10-year community study. BMJ 1988; 296: 612–14.
8.Pollock TM, Miller E, Lobb J. Severity of whooping cough in England before and after the decline in pertussis immunisation. Arch Dis Child 1984; 59: 162–5.
9.Miller E, Jacombs B, Pollock TM. Whooping cough notifications. Lancet 1980; i: 718.
10.Orenstein WA, Bernier RH, Donder TJ, et al. Field evaluation of vaccine efficacy. Bull WHO 1985; 63: 1055–68.
11.Begg NT, Gill ON, White JM. COVER (Cover of Vaccination Evaluated Rapidly): description of the England and Wales scheme. Public Health 1989; 103: 81–9.
12. World Health Organisation. Report of a meeting on the case definition of pertussis. MIM/EPI/PERT/91.1 Geneva: WHO, 1991.
13.Onorato IM, Wassilak SGF. Laboratory diagnosis of pertussis: the state of the art. Paediatr Infect Dis J 1987; 6: 145–51.
14.Jenkinson D, Pepper JD. A search for subclinical infection during a small outbreak of whooping cough: implications for clinical diagnosis. J R Coll Gen Pract 1986; 36: 547–8.
15.Grob PR, Crowder MJ, Robbins JF. Effect of vaccination on the severity and dissemination of whooping cough. BMJ 1981; 282: 1925–8.
16. Swansea Research Unit of the Royal College of General Practitioners. Effect of a low pertussis vaccination uptake on a large community. BMJ 1981; 282: 23–36.
17.Miller CL, Fletcher WB. Severity of notified whooping cough. BMJ 1976; i: 117–19.
18.Palmer SR. Vaccine efficacy and control measures in pertussis. Arch Dis Child 1991; 66: 854–7.
19.Orenstein WA, Bernier RH, Hinman AR. Assessing vaccine efficacy in the field. Further observations. Epidemiol Rev 1988; 10: 212–41.
20.Fine PEM, Clarkson JA. Reflections of the efficacy of pertussis vaccines. Rev Infect Dis 1987; 9: 866–83.
21.Farrington CP. The measurement and interpretation of age specific vaccine efficacy. Int J of Epidemiol 1992; 21: 1014–20.